Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("SEIDMAN, Andrew D")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 38

  • Page / 2
Export

Selection :

  • and

Emerging targeted therapies for breast cancerARNEDOS, Monica; SEIDMAN, Andrew D.Hematology/oncology clinics of North America. 2007, Vol 21, Num 2, issn 0889-8588, vii, 321-340 [21 p.]Article

The evolving role of gemcitabine in the management of breast cancerSEIDMAN, Andrew D.Oncology. 2001, Vol 60, Num 3, pp 189-198, issn 0030-2414Article

Treatment Strategies for Patients with Anthracycline- and Taxane-Pretreated Metastatic Breast CancerSEIDMAN, Andrew D.Seminars in oncology. 2008, Vol 35, Num 2, issn 0093-7754, 37 p., SUP2Serial Issue

Current and emerging systemic treatment strategies for breast cancerSEIDMAN, Andrew D.Hematology/oncology clinics of North America. 2007, Vol 21, Num 2, issn 0889-8588, 200 p.Serial Issue

Current status of dose-dense chemotherapy for breast cancerSEIDMAN, Andrew D.Cancer chemotherapy and pharmacology. 2005, Vol 56, issn 0344-5704, s78-s83, SUP1Article

Dose-dense treatment prolongs disease-free survival of women with node positive breast cancerCHAU DANG; SEIDMAN, Andrew D.Cancer treatment reviews. 2003, Vol 29, Num 5, pp 453-456, issn 0305-7372, 4 p.Article

Preclinical Investigations With Epothilones in Breast Cancer ModelsBURNS, Howard A.Seminars in oncology. 2008, Vol 35, Num 2, issn 0093-7754, S15-S21, SUP2Article

Clinical Studies With Epothilones for the Treatment of Metastatic Breast CancerVAHDAT, Linda T.Seminars in oncology. 2008, Vol 35, Num 2, issn 0093-7754, S22-S30, SUP2Article

Adjuvant endocrine treatment of early breast cancerLONNING, Per Eystein.Hematology/oncology clinics of North America. 2007, Vol 21, Num 2, issn 0889-8588, v, 223-238 [17 p.]Article

Hormonal therapy for advanced breast cancerRUGO, Hope S.Hematology/oncology clinics of North America. 2007, Vol 21, Num 2, issn 0889-8588, vi, 273-291 [20 p.]Article

Monotherapy options in the management of metastatic breast cancerSEIDMAN, Andrew D.Seminars in oncology. 2003, Vol 30, Num 2, pp 6-10, issn 0093-7754, 5 p., SUP3Article

Cardiac effects of adjuvant therapy for early breast cancerTHEODOULOU, Maria; SEIDMAN, Andrew D.Seminars in oncology. 2003, Vol 30, Num 6, pp 730-739, issn 0093-7754, 10 p., SUP19Conference Paper

Cellular Mechanisms of Resistance to Anthracyclines and Taxanes in Cancer : Intrinsic and AcquiredCHIEN, A. Jo; MOASSER, Mark M.Seminars in oncology. 2008, Vol 35, Num 2, issn 0093-7754, S1-S14, SUP2Article

Emerging Agents in the Treatment of Anthracycline-and Taxane-Refractory Metastatic Breast CancerDEAN-COLOMB, Windy; ESTEVA, Francisco J.Seminars in oncology. 2008, Vol 35, Num 2, issn 0093-7754, S31-S38, SUP2Article

Brain metastases : Old problem, new strategiesNGUYEN, Teri D; ABREY, Lauren E.Hematology/oncology clinics of North America. 2007, Vol 21, Num 2, issn 0889-8588, vii-viii, 369-388 [22 p.]Article

Critical review of current treatment strategies for advanced hormone insensitive breast cancerVAN POZNAK, Catherine; SEIDMAN, Andrew D.Cancer investigation. 2002, Vol 20, pp 1-14, issn 0735-7907, 14 p., SUP2Conference Paper

Adjuvant chemotherapy for early-stage breast cancerMCARTHUR, Heather L; HUDIS, Clifford A.Hematology/oncology clinics of North America. 2007, Vol 21, Num 2, issn 0889-8588, v, 207-222 [17 p.]Article

HER2-positive advanced breast cancerROBERT, Nicholas J; FAVRET, Anne M.Hematology/oncology clinics of North America. 2007, Vol 21, Num 2, issn 0889-8588, vi-vii, 293-302 [12 p.]Article

Chemotherapy for metastatic breast cancerMAYER, Erica L; BURSTEIN, Harold J.Hematology/oncology clinics of North America. 2007, Vol 21, Num 2, issn 0889-8588, vi, 257-272 [17 p.]Article

Bisphosphonates for breast cancer : Questions answered, questions remainingLAYMAN, Rachel; OLSON, Karin; VAN POZNAK, Catherine et al.Hematology/oncology clinics of North America. 2007, Vol 21, Num 2, issn 0889-8588, vii, 341-367 [28 p.]Article

Trastuzumab (herceptin) for early-stage breast cancerISMAEL, Gustavo; DORNELLES ROSA, Daniela; DE AZAMBUJA, Evandro et al.Hematology/oncology clinics of North America. 2007, Vol 21, Num 2, issn 0889-8588, v-vi, 239-256 [20 p.]Article

Clinical Cancer Advances 2011: Annual Report on Progress Against Cancer From the American Society of Clinical OncologyVOGELZANG, Nicholas J; BENOWITZ, Steven I; PATEL, Jyoti D et al.Journal of clinical oncology. 2012, Vol 30, Num 1, pp 88-109, issn 0732-183X, 22 p.Article

Feasibility Trial of Letrozole in Combination With Bevacizumab in Patients With Metastatic Breast CancerTRAINA, Tiffany A; RUGO, Hope S; SEIDMAN, Andrew D et al.Journal of clinical oncology. 2010, Vol 28, Num 4, pp 628-633, issn 0732-183X, 6 p.Article

Phase II study of feasibility of dose-dense FEC followed by alternating weekly taxanes in high-risk, four or more node-positive breast cancerDANG, Chau T; D'ANDREA, Gabriella M; HURRIA, Arti et al.Clinical cancer research. 2004, Vol 10, Num 17, pp 5754-5761, issn 1078-0432, 8 p.Article

Randomized Phase III Trial of Weekly Compared With Every-3-Weeks Paclitaxel for Metastatic Breast Cancer, With Trastuzumab for all HER-2 Overexpressors and Random Assignment to Trastuzumab or Not in HER-2 Nonoverexpressors : Final Results of Cancer and Leukemia Group B Protocol 9840SEIDMAN, Andrew D; BERRY, Donald; UNGARO, Peter et al.Journal of clinical oncology. 2008, Vol 26, Num 10, pp 1642-1649, issn 0732-183X, 8 p.Article

  • Page / 2